SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-20-017925
Filing Date
2020-10-16
Accepted
2020-10-16 16:40:47
Documents
2
Period of Report
2020-10-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 2999
2 POWER OF ATTORNEY poa_floyd.htm EX-24 8120
  Complete submission text file 0001567619-20-017925.txt   12704
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Issuer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PROCESSA PHARMACEUTICALS, INC. 7300 COCA COLA DRIVE, SUITE 106 HANOVER MD 21076
Business Address
Floyd Robert Michael (Reporting) CIK: 0001828217 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39531 | Film No.: 201244410